UK must reform drug pricing to become life sciences superpower, says GSK boss
Shares jump on higher profits as Emma Walmsley is ‘hopeful’ standoff with NHS can be resolved
The GuardianOct 29, 2025
Read full articleLatest News
Drug firm GSK delivers a syringe full of crowd-pleasers
Pharmaceuticals company’s higher dividend, upgrade to revenues and share buyback suggest its drugs pipeline is flowing nicely
The GuardianFeb 5, 2025
Read full article
Victoria's Secret book 'Selling Sexy' reports brand's downfall
Victoria's Secret found retail success before the brand began to fail, from the new book Selling Sexy.
FortuneOct 11, 2024
Read full article
GSK shares jump after settlement of 80,000 Zantac lawsuits in U.S
The agreement, announced on Wednesday, was far lower than some analyst estimates, including JP Morgan's projection of $3.5 billion. Analysts at Jefferies said the settlement of the cases should remove "the majority of Zantac overhang on the stock".
Yahoo FinanceOct 10, 2024
Read full article
GSK agrees to settle about 80,000 Zantac lawsuits for up to $2.2 billion
GSK has agreed to pay up to $2.2 billion to settle most lawsuits in US state courts claiming that a discontinued version of the heartburn drug Zantac caused cancer, the company announced on Wednesday.
Cable News NetworkOct 9, 2024
Read full article
GSK strikes $2.2bn deal to resolve legal cases in US over heartburn treatment Zantac
British drugmaker agrees payment to resolve 80,000 cases alleging cancers were linked to drug known generically as ranitidine
The GuardianOct 9, 2024
Read full article
GSK’s health is improving. Shame about the legal heartburn
Emma Walmsley’s overhaul seems to be delivering the goods even if US worries have left the share price becalmed
The GuardianJul 31, 2024
Read full article
Bird Flu Concerns & Global Health Developments
The summary highlights recent health news, focusing on the rising concern among scientists regarding a potential bird flu pandemic and various updates in the pharmaceutical industry. Notable points include Blackstone's sale of Alinamin, a Chinese robot 'guide dog' innovation for the visually impaired, and new regulations in Australia regarding vape sales.
DevdiscourseJul 2, 2024
Read full article
Moderna-Merck's Melanoma Breakthrough & Health Updates
In recent health news, Moderna and Merck reported a significant survival benefit for melanoma patients using their combined cancer vaccine and Keytruda. Meanwhile, Anthony Fauci refutes COVID-19 lab leak suppression allegations, and there are updates on Bayer, GSK, J&J, and other health-related legal and pharmaceutical developments.
DevdiscourseJun 5, 2024
Read full article
Breaking Health News: Innovations, Controversies, and Legal Battles
This summary of recent health news highlights significant developments, from Moderna and Merck's promising skin cancer vaccine to legal challenges faced by GSK and Johnson & Johnson. Additional topics include Dr. Fauci addressing COVID-19 origins, Finland's reduction in teenage abortions, and advances in neurological and avian disease research.
DevdiscourseJun 4, 2024
Read full article
Biopharma Breakthroughs: IPOs, Vaccines, and Medical Advancements
Current health news includes a $637 million IPO for Rapport Therapeutics, promising survival data for a Moderna-Merck skin cancer vaccine, and successful trials for Agios Pharmaceuticals' blood disorder drug. Additionally, significant legal and business developments impact firms like J&J, GSK, and Edwards Lifesciences.
DevdiscourseJun 4, 2024
Read full article
DC attorney general reaches $40 million tax case settlement with founder of MicroStrategy
Stories you may have missed from the world of business.
The Boston GlobeJun 3, 2024
Read full article
Health News Roundup: Pfizer offers up to $250 million to settle Zantac cancer lawsuits, FT reports; Novo Nordisk owner buys majority stake in Austrian life science tools company and more
Following is a summary of current health news briefs. Exclusive-Musk's Neuralink has faced issues with its tiny wires for years, sources say Neuralink's disclosure last week that tiny wires inside the brain of its first patient had pulled out of position is an issue the Elon Musk company has known about for years, according to five people familiar with the matter.
DevdiscourseMay 16, 2024
Read full article
Pfizer offers up to $250 million to settle Zantac cancer lawsuits, FT reports
The drugmaker was set to pay between $200 million and $250 million in the settlement, the newspaper reported, citing two people briefed on the deal. The settlement was disclosed in a court filing in Delaware last week, and is aimed at reducing Pfizer's potential liability, the report added. Pfizer did not immediately reply to Reuters' request for comment.
Yahoo FinanceMay 16, 2024
Read full article
Sanofi reportedly settles 4K Zantac cases for $100M
Sanofi (SNY) has reportedly agreed to pay over $100M to settle around 4,000 cases filed over the safety of its heartburn drug Zantac. Read more here.
Seeking AlphaApr 22, 2024
Read full article
Sanofi to settle 4,000 Zantac cancer lawsuits in US state courts
Sanofi has reached an agreement in principle to settle 4,000 US lawsuits linking the discontinued heartburn drug Zantac to cancer, the company said on Wednesday.
Cable News NetworkApr 5, 2024
Read full article
Today’s Latest Business News, Finance and Share Market News at 5:30 pm on 4 April 2024
In today's podcast, we talk about India’s Services PMI and KEC International witnessing a spike of 15% among other news. Also, know how the market closed today.
The Indian ExpressApr 4, 2024
Read full article
Sanofi agrees to settle ~4K Zantac cancer lawsuits in the U.S. (NASDAQ:SNY)
Sanofi (SNY) on Wednesday said it had agreed to settle about 4K Zantac cancer lawsuits in all U.S. states outside of Del. Read more here.
Seeking AlphaApr 3, 2024
Read full article
GSK settles another Zantac lawsuit in California
GSK settles another Zantac lawsuit in California
Investing.comJan 31, 2024
Read full article
US lawsuit settlement puts spotlight back on ranitidine. India still undecided on 'cancer-risk' drug
Ranitidine still sold as popular heartburn medicine in India despite being banned or suspended in US, Europe & Australia. It was dropped from essential medicines list last year.
ThePrintOct 13, 2023
Read full articleSubmit Your Claim Information
If you believe you have a legal claim, fill out the form below. This is for demonstration purposes only.
PROVIDING YOUR INFORMATION DOES NOT ESTABLISH AN ATTORNEY-CLIENT RELATIONSHIP AND YOUR INFORMATION MAY BE SHARED WITH A DIFFERENT LAW FIRM WHO MAY CONTACT YOU.